Oral Contraceptives, HRT and SERMS Flashcards

1
Q

Oral Contraceptive Pill (OCP):

A

-Synthetic combination of Progesterone and Estrogen.
•Combination of Estrogen and progestin through 21 days- 7 days placebo
•When the combined pill is withdrawn, normal bleeding occurs, mimicking normal menstruation (but during the cycle there is NO ovulation)- pregnancy is avoided.
–>Blocks ovulation by keeping FSH/ LH levels low.
-Administration of progesterone changes the endometrium lining, ensuring it stays thick so sperm stays impermeable to the wall.
-Keep FSH/ LH levels low throughout a women’s cycle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

True or False: Estradiol undergoes first pass metabolism in the liver.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Ethinylestradiol (EE2) or Mestranol

A

Synthetic Estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Levonorgestrel, Norethynodrel, Norgestrel

A

Synthetic Progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Adverse Effects and Contraindications of OCP:

A
  • Estrogen Beneficial Effect- Includes plasma HDL levels and decreases bone resorption caused by PTH
  • Estrogen’s undesirable effects: Includes nausea, vomiting, mastalgia (breast pain), edema and skin hyper pigmentation- Chloasma, and increased withdrawal bleeding.
  • ->If noticed, decrease the dose of EE2 in the OCP.
  • COULD increase coagulation factors (clots/ venous thromboembolism risk)

-Always watch for symptoms or family history of stroke, heart failure, VTE, Peripheral Artery Disease, ect. with OCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

OCP risk of DDI’s?

A

-OCP have decreased efficacy when taken with antibiotics (reduces efficacy due to increased intestinal excretion by reducing the enterohepatic reabsorption of estrogen.

  • Estradiol glucuronide (E2- G) presented in the gut from the liver via bile is broken down by bacterial beta- glucuronidase to free E2, which undergoes enterohepatic circulation.
  • ->In the absence of gut microflora following a long term antibiotic regimen, more estradiol is excreted as E2 glucuronide conjugate in the feces, reducing E2 reabsorption resulting in decreased E2 bioavailability.

-Drugs which cause this decrease in efficacy include Carbamazepine, Phenytoin & Rifampin (increase hepatic metabolism of EE2 in OCP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Transdermal Hormonal Contraceptive Patch:

A
  • Wearing the patch containing estrogen/ progesterone for 3 weeks on and 1 week off.
  • Better adherence compared to OCP- presents a higher level of EE2.

Drawbacks:

  • Lower efficacy in obese women
  • Possibility of increased thromboembolic risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The Nuva Ring

A
  • Type of Vaginal Ring
  • Inserted on the 5th day of the menstrual cycle and releases 15 ug of Ethinyl Estradiol (EE2) and 120 ug of Etonogesterl.

–Give 1 week off and start again on day 5 after menses.

Drawbacks: Sudden expulsion- lowers its efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Progesterone- Only Preparations:

A
  • Parental Administration
  • Ideal for women intolerant to estrogen

3 Types:

  1. Depot Medroxyprogesterone Acetate (DMPA): 150 mg (deep IM administration every 3 months).
  2. DMPA- given SC (longer duration of action)
  3. Subdermal Depot Progestin Implant
    - Norplant is effective for 6 months
    - Nexplanon is 68 mg Etonogesterel (4cm implant placed under the skin, which slowly releases Etonogesterel (60-30ug/ day) over 3 years.
    * All are 99% effective.

Drawbacks: Irregular bleeding, vaginitis, lack of menstrual cycle and delayed onset of ovulatory cycle, as well as not having a regular menstrual cycle is worrisome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Copper IUD:

A
  • Copper wire in the IUD interferes with sperm movement and Nidation (Implantation).
  • Requires a health professional to insert (can caused painful periods- dysmenorrhea), increased uterine PG formation, uterine/ pelvic inflammation and allergy to copper are all adverse effects.
  • Expulsion is the drawback
  • ->Cost= $200 (Safe for up to 5 years)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Progesterone Releasing Plastic IUD (Mirena):

A
  • Superior over Copper- T IUD
  • Higher cost ($600-900)- low and sustained Levonorgestrel release serves as an effective contraceptive.
  • -Mirena is the drug Trade name
  • Efficacy is much better (>99%)
  • Drawbacks include expulsion, reduced and irregular menstruation, cramping pain, weight gain, acne and hair growth.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Emergency Contraception/ Plan B:

A
  • Post Coital Progestin
  • Taken within 72 hours of coitus
  1. 1 tablet is a high dose Levonorgesterel
  2. 1 tablet is an intermediate dose of 1. 1 tablet is a high dose Levonorgestrel followed by another tablet within 12 hours.
  3. Ulipristal Acetate (a SPRM) -single dose (30mg) tablet within 120 hours of coitus
    - -SPERM is a selective progesterone receptor modulator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ulipristal Acetate:

A
  • -Progestin Antagonist
  • -Doesn’t allow for maintenance of the fertilized egg.
  • A single dose (30mg) tablet within 120 hours of coitus
  • -SPERM is a selective progesterone receptor modulator

Mechanism of Action:
-Both estrogen and progestin together is required for implantation to maintain pregnancy. A very high dose of progestin per se interferes with the process of implantation. With the sudden decrease in progestin, there is withdrawal bleeding and the fertilized egg dislodges.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mifepristone (RU486):

A
  • Progesterone Antagonist
  • dosed at 400-600 mg per day for 4 days with prostaglandin (PGE1 or 15 methyl PGF2alpha)
  • Mifepristone is a steroid- acts as a competitive blocker of both progesterone and glucocorticoid.
  • Allows for the termination of pregnancy up to 53 days.
  • Also useful in the management of Cushing Syndrome (Excess Cortisol) & Endometriosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Methotrexate:

A
  • First trimester abortifacient (MTP)
  • Cytotoxic agent towards the placenta- given along with uterine stimulants such as Misoprostol- PGE1 analog (600-800 mg) or 15 methyl PGF2alpha administration would stimulate uterine contraction and disrupt the fetus, leading to fetal expulsion.
  • -In Canada, Methotrexate & Prostaglandins aren’t used for the termination of pregnancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hormonal Replacement Therapy– Benefits of Ethinyl Estradiol (EE2):

A

Advantages: Better Sleep, CV protective, reduced osteoporosis, reduced urethritis, vaginal atrophy, as well as reduced hot flashes.

Drawbacks: Susceptible to breast cancer, endometrial cancer, VTE and Stroke

17
Q

How can we overcome these potential drawbacks of HRT using EE2?

A

SERMS

  • Selective Estrogen Response Modifiers
  • Using SERMS instead of Estrogens to overcome the disadvantageous aspects of estrogens
18
Q

Fulvestant:

A
  • non selective SERM
  • A steroidal competitive antagonist at all Estrogen receptors (derivative of estradiol)
  • Effective in the early management of estrogen dependent breast carcinoma when Tamoxifen fails.
19
Q

Tamoxifen*:

A
  • A non-steroidal partial agonist and a SERM
  • Blocks estrogen receptors in the breast, and therefore is useful in the early stages of treatment of estrogen- dependent breast carcinoma.

Drawbacks:

  • Promotes estrogenic activity in the endometrium and a cause for a risk of endometrial carcinoma.
  • Enhances deep vein thrombosis and pulmonary embolism.
  • It can enhance clotting factor production like estradiol, although it blocks the estrogen receptors in the breast.
20
Q

Clomiphene Citrate*:

A
  • SERM
  • A non steroidal agent
  • Increases FSH/ LH release and induces ovulation.
  • A weak estrogen receptor with striking antagonist effect selectively on the HPA axis estrogen receptors. BY binding tightly, it blocks estrogen induced inhibition of FSH/ LH release and induces ovulation.

*Used to treat secondary amenorrhea and anovulatory menstrual cycles.

Adverse Effects:
-Hot flushes, alopecia and headaches.
Toxicity: Multiple pregnancies, ovarian hyper stimulation syndrome (OHSS) and ovarian rupture (can lead to ovarian cancer)

21
Q

(hMG- Human Menopausal Gonadotropin; hCG) and Bromocriptine:

A
  • Ovulation Inducing Agents:

- ->(In case there is Hyperprolactemia- can cause secondary amenorrhoea)

22
Q

Raloxifene*:

A
  • A non steroidal SERM
  • Mimics estrogen effect on the bone and decrease PTH induced bone resorption
  • Helpful in the treatment of osteoporosis in post-menstrual women
  • Likelihood of estrogens- induced breast/ endometrial carcinoma (when estrogen is used for the HRT) is avoided by using this agent.

–A good alternative to estrogens to protect against osteoporosis in post- menopausal women.

Drawback: Could cause deep vein thrombosis and pulmonary embolism.